Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David T Gilbertson

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2022
Associations of COVID-19 Outcomes with Dialysis Modalities and SettingsEric D Weinhandl, Jiannong Liu, David T Gilbertson, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United StatesJon J Snyder, Robert N Foley, David T Gilbertson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2007
Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003Eric D Weinhandl, Madhumati Rao, David T Gilbertson, et al.
Nephrology (Carlton, Vic.)|July 1, 2010
Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education programAllan J Collins, David T Gilbertson, Jon J Snyder, et al.
Kidney International|February 14, 2014
Early mortality in patients starting dialysis appears to go unregisteredRobert N Foley, Shu-Cheng Chen, Craig A Solid, et al.
Kidney International|October 9, 2003
Body size and outcomes on peritoneal dialysis in the United StatesJon J Snyder, Robert N Foley, David T Gilbertson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 20, 2007
Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002Robert N Foley, Rui Zhang, David T Gilbertson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2009
Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis populationThomas J Arneson, David Zaun, Yi Peng, et al.
Kidney International|November 18, 2011
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studiesJiannong Liu, Eric D Weinhandl, David T Gilbertson, et al.
Journal of the American Society of Nephrology : JASN|August 5, 2005
General medical care among patients with chronic kidney disease: opportunities for improving outcomesAnnamaria T Kausz, Haifeng Guo, Brian J G Pereira, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Clinical Journal of the American Society of Nephrology : CJASN|November 18, 2022
Associations of COVID-19 Outcomes with Dialysis Modalities and SettingsEric D Weinhandl, Jiannong Liu, David T Gilbertson, et al.
Journal of the American Society of Nephrology : JASN|December 25, 2003
Hemoglobin levels and erythropoietin doses in hemodialysis and peritoneal dialysis patients in the United StatesJon J Snyder, Robert N Foley, David T Gilbertson, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 24, 2007
Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003Eric D Weinhandl, Madhumati Rao, David T Gilbertson, et al.
Nephrology (Carlton, Vic.)|July 1, 2010
Chronic kidney disease awareness, screening and prevention: rationale for the design of a public education programAllan J Collins, David T Gilbertson, Jon J Snyder, et al.
Kidney International|February 14, 2014
Early mortality in patients starting dialysis appears to go unregisteredRobert N Foley, Shu-Cheng Chen, Craig A Solid, et al.
Kidney International|October 9, 2003
Body size and outcomes on peritoneal dialysis in the United StatesJon J Snyder, Robert N Foley, David T Gilbertson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|June 20, 2007
Exceeding hemoglobin target levels in US hemodialysis patients receiving epoetin, 1999 to 2002Robert N Foley, Rui Zhang, David T Gilbertson, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 7, 2009
Comparison of methodologies to characterize haemoglobin variability in the US Medicare haemodialysis populationThomas J Arneson, David Zaun, Yi Peng, et al.
Kidney International|November 18, 2011
Issues regarding 'immortal time' in the analysis of the treatment effects in observational studiesJiannong Liu, Eric D Weinhandl, David T Gilbertson, et al.
Journal of the American Society of Nephrology : JASN|August 5, 2005
General medical care among patients with chronic kidney disease: opportunities for improving outcomesAnnamaria T Kausz, Haifeng Guo, Brian J G Pereira, et al.
Pageof 17